The art of being present promises three things in a row, and the phrase carries them so smoothly that you can miss how different they are. Calm. Purpose. Focus. Two of those have been measured in controlled trials, one of them has not, and the measured pair came back with very different answers.
Worth saying at the outset what this is and is not. This is a reading of two pieces of research, not clinical advice, and nothing below is a reason for anyone to stop doing something they find valuable.
The strictest analysis anyone has run
In 2014, Madhav Goyal and colleagues at Johns Hopkins screened 17,801 citations and kept 47 trials covering 3,320 participants. The inclusion rule is the whole story: they took only randomized trials with active controls, meaning the comparison group was also given something to do rather than being put on a waiting list.
The Artful Age
A weekly letter on aging well, family across generations, and the creative life after the kids leave home.
That rule is why their numbers are lower than the ones usually quoted. A person who spends eight weeks in a class getting attention, structure and the expectation of improvement tends to improve somewhat, whatever the class is about. An active control is the attempt to subtract that.
What survived the subtraction:
Anxiety improved, with moderate evidence, at an effect size of 0.38 at eight weeks (confidence interval 0.12 to 0.64). At three to six months it was 0.22 (0.02 to 0.43). Depression improved by 0.30 at eight weeks (0.00 to 0.59), and 0.23 at three to six months (0.05 to 0.42). Pain improved by 0.33 (0.03 to 0.62).
Those are small to moderate effects, they shrink at follow-up, and the eight-week depression interval touches zero. They are also real, and the authors treat them as real.
Then the part that answers the title
For positive mood, attention, substance use, eating, sleep and weight, the finding was, in the authors’ phrasing, either low evidence of no effect or insufficient evidence of any effect.
Attention is the thing the word focus means. Positive mood is a fair reading of what most people are hoping for. On the best-controlled evidence available, neither has been shown.
And there is one more result that people who quote this literature tend to leave out. The authors found no evidence that meditation programs were better than any other active treatment, and they name the comparisons: drugs, exercise, other behavioral therapies. Meditation held its own. It did not win.
As for purpose, the third promise, it was not an outcome in either paper. That is not a null result. It is an absence, and it is more honest to say so than to quietly drop it.
What the word “art” is hiding
Here is the fact that reframes the entire genre, and it comes from the other paper.
The gold-standard protocol behind most of these numbers is the eight-week mindfulness-based stress reduction course. That is 20 to 26 hours of formal training, delivered in eight weekly classes of one and a half to two and a half hours, plus one six-hour day, plus home practice of roughly 45 minutes a day, six days a week.
That is the dose that produced 0.38. Not a shift in outlook, not a way of holding your attention while you wash up. Something closer to a part-time course with homework, for two months.
Anyone is free to do less, and doing less may well be pleasant. But the numbers people cite when they recommend presence were bought at that price, and the article that sells the price as an art quietly detaches the result from the thing that produced it.
How solid is any of this
In 2018, fifteen researchers published an audit of the field, and it is worth knowing who they are. They are not outside skeptics. Several are meditation scientists and practitioners, and they say explicitly that their target is hype in both directions, the exaggerated positive claims and the exaggerated negative ones.
Their picture of the research base is sobering. Citing an audit against the National Institutes of Health stage model for clinical science, they report that only about 30 percent of mindfulness-based intervention research has moved past the first stage, the one where you are still generating and refining the intervention. Most of what has moved on was tested against a waiting list or against treatment as usual. Just 9 percent of the total reaches the stage of being tested against an active control. And 1 percent has been conducted outside a research setting.
They also raise something that takes care to report accurately. Fewer than a quarter of meditation trials actively assess adverse effects, against 100 percent of pharmacology trials, and they note that relying on people to mention problems unprompted can understate how often those problems occur by more than twentyfold.
The distinction they draw is the one that matters. They are not saying meditation is dangerous. They are saying that the widespread assumption it carries no risks rests, in their words, on a lack of research rather than on substantive evidence. Those are different sentences, and the difference is the entire point.
It is also worth knowing that the field itself has not ignored this. Both the University of Massachusetts Center for Mindfulness and the Oxford Mindfulness Centre publish exclusion criteria for their standard courses, and many centers state plainly that mindfulness is not intended to replace standard psychiatric care. That is a field taking a question seriously, not hiding one.
What is actually left, and it is not nothing
Goyal and colleagues did not conclude that any of this was worthless, and their own summary deserves to be quoted rather than paraphrased into something harder. Clinicians, they wrote, should be aware that meditation programs can result in small to moderate reductions in multiple negative dimensions of psychological stress, and should be prepared to talk with patients about the role such a program might have.
That is a modest, useful, defensible thing to know. A serious eight-week course, properly done, moves anxiety and low mood a little, and moves pain a little, and the movement fades somewhat over the following months. It does not appear to sharpen attention. It does not appear to beat going for a run.
None of which is an argument against sitting quietly. If twenty minutes in a chair makes your afternoon better, the evidence has nothing to say against that and neither does anyone else. What the evidence does argue against is the packaging: the idea that presence is an art you acquire, that it delivers focus, and that the research has settled the matter. On the best available reading, the first is a course of training, the second has not been demonstrated, and the third is a field that by its own auditors’ account has barely started.